Laboratory-Grade Recombinant Human Growth Hormone
ZPTROP HGH 320IU is a recombinant human growth hormone (somatropin) research preparation manufactured by ZPHC Zhengzhou Pharmaceutical Co. This pharmaceutical-grade compound enables comprehensive laboratory investigations into somatotropin receptor interactions, cellular proliferation mechanisms, and metabolic pathway modulation. Research scientists at Stroid UK Shop utilise this preparation to examine growth hormone signalling cascades and anabolic cellular responses in controlled experimental conditions.
Scientific Research Applications
Laboratory studies investigate ZPTROP’s interaction with growth hormone receptors and subsequent activation of JAK-STAT signalling pathways. Research applications include examining protein synthesis regulation, lipolytic pathway activation, and IGF-1 mediated cellular responses. Scientists studying growth hormone preparations investigate this compound’s effects on cellular glucose uptake, amino acid transport mechanisms, and mitochondrial biogenesis. Advanced research protocols compare somatropin activity with other investigational compounds available through our selective androgen receptor modulator and peptide research collections. The 320IU concentration provides researchers with standardised dosing for reproducible experimental protocols examining growth hormone’s pleiotropic cellular effects.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Recombinant Human Growth Hormone |
| Concentration | 320 International Units |
| Manufacturer | ZPHC Zhengzhou Pharmaceutical Co. |
| Purity | Verify with supplier documentation |
| Molecular Formula | C₉₉₀H₁₅₂₈N₂₆₂O₃₀₀S₇ |
| Molecular Weight | 22,124.11 g/mol |
| Storage Requirements | 2-8°C refrigerated, protect from light |
| Solubility | Reconstitute with bacteriostatic water |
Research Compliance
ZPTROP HGH 320IU is manufactured exclusively for in-vitro research applications and laboratory investigations. This compound is not approved for human consumption, therapeutic use, or clinical administration. Research facilities must maintain appropriate storage conditions and handling protocols. Scientists should verify compound specifications through supplier documentation before initiating experimental protocols. All investigations must comply with institutional research guidelines and safety protocols for handling pharmaceutical-grade research materials.
